Rash and pulmonary eosinophilia associated with fenbufen.
Burton
G H
GH
Medicines Control Agency, Department of Health, London.
D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D010003:Osteoarthritis / Q000188:drug therapy; D010654:Phenylbutyrates / Q000009:adverse effects* / Q000627:therapeutic use; D011657:Pulmonary Eosinophilia / Q000139:chemically induced*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010654:Phenylbutyrates; C010725:fenbufen